September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
A New Quantitative Approach in Analyzing Polypoidal Choroidal Vasculopathy In Vivo Using En Face Optical Coherence Tomography
Author Affiliations & Notes
  • Jonathan Chou
    Ophthalmology, Massachusetts Eye & Ear Infirmary, Cambridge, Massachusetts, United States
  • Errol Chan
    Ophthalmology, National University Hospital, Singapore, Singapore
  • Joseph Simonett
    Ophthalmology, Northwestern University , Chicago, Illinois, United States
  • Amani A Fawzi
    Ophthalmology, Northwestern University , Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Jonathan Chou, None; Errol Chan, None; Joseph Simonett, None; Amani Fawzi, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4257. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jonathan Chou, Errol Chan, Joseph Simonett, Amani A Fawzi; A New Quantitative Approach in Analyzing Polypoidal Choroidal Vasculopathy In Vivo Using En Face Optical Coherence Tomography. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4257.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To describe a new approach for quantifying the polypoidal choroidal vasculopathy (PCV) lesions and to monitor their response to anti-VEGF therapy using en face volumetric spectral domain optical coherence tomography.

Methods : A total of 13 eyes from 12 patients with a clinical diagnosis of PCV were analyzed. We used the macular volume scan (6x6mm cube) reviewed on Cirrus (Carl Zeiss Meditec Inc, Dublin, CA) to identify pigment epithelial detachments, subretinal fluid, and vascular lesions seen in the disease process. OCT slab function was used to create a topographic map following the contour of the RPE. The entire neovascular PCV lesion (including polyps, branching vascular network and pigment epithelial detachment) was identified as a hypo-reflective network. ImageJ was used for all analysis. Two masked graders created a topographic binary map of the PCV lesions by thresholding the en face image to isolate the hypo-reflective areas. The total lesion area was compared between the two graders to determine inter-rater reliability. Further analysis compared lesion areas in patients before and after an anti-VEGF induction series of 1-8 injections (ranibizumab or bevacizumab). Pearson correlation coefficient, Bland-Altman scale, and a student t-test with a p-value <0.05 were used in the statistical analysis.

Results : Inter-rater reliability for lesion area measurements had a Pearson correlation of 0.960. Of the 13 eyes, 10 had no prior history of treatment. The en face lesion area decreased from 2.75 mm2 to 2.22 mm2 after anti-VEGF injections (p = 0.047). 3 eyes had previously been treated with photodynamic therapy. In these eyes, the lesion area decrease was not statistically significant (2.66 mm2 to 2.21 mm2). In a sub-group analysis comparing patients treated with ranibizumab vs. bevacizumab, there was no statistical difference in the reduction of the lesion area (-0.43 mm2 to -0.58 mm2, respectively)

Conclusions : Using SD-OCT, we have described a new approach for accurately quantifying the entire pathology seen in PCV with good inter-rater reliability. With this technique, we have shown a significant reduction in PCV lesion area following anti-VEGF therapy in treatment-naive eyes.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

 

A) SD-OCT b-scan showing multiple RPE elevations suggestive of polypoidal lesions, subretinal fluid and fibrin deposits. B) Corresponding en face OCT slab at the level of the RPE.

A) SD-OCT b-scan showing multiple RPE elevations suggestive of polypoidal lesions, subretinal fluid and fibrin deposits. B) Corresponding en face OCT slab at the level of the RPE.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×